Article Information
History
- August 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pratheusa Machha1,2,
- Amirtha Gopalan3,4,
- Yamini Elangovan5,
- Sarath Chandra Mouli Veeravalli3,
- Divya Tej Sowpati1,2 and
- Kumarasamy Thangaraj1,2,*
- 1CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana - 500007, India
- 2Academy of Scientific and Innovative Research (AcSIR), Ghaziabad - 201002, India
- 3Department of Rheumatology and Clinical Immunology, Krishna Institute of Medical Sciences, Secunderabad, Telangana - 500003, India
- 4Department of Rheumatology and Clinical Immunology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana - 500082, India
- 5Department of Biotechnology, Bharathidasan University, Tiruchirapalli, Tamil Nadu - 620024, India
- ↵*Correspondence to K. Thangaraj, CSIR-Centre for Cellular and Molecular Biology Uppal Road, Hyderabad, India – 500007, Email: thangs{at}ccmb.res.in, Tel: +91-40-27192634
Posted August 29, 2024.
Endogamy and high prevalence of deleterious mutations in India: evidence from strong founder events
